TSPO and delirium: Advanced imaging techniques using PET with translocator protein (TSPO) ligands have visualized microglial activation in human patients experiencing delirium, with 25–40% increased binding potential in hippocampal and prefrontal regions, which underly memory and executive processes, compared to non-delirious controls, typically measured 3–7 days after surgery [64].